1. Home
  2. GHM vs HROW Comparison

GHM vs HROW Comparison

Compare GHM & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graham Corporation

GHM

Graham Corporation

HOLD

Current Price

$106.46

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$41.37

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHM
HROW
Founded
1936
1998
Country
United States
United States
Employees
N/A
373
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
GHM
HROW
Price
$106.46
$41.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$73.33
$69.86
AVG Volume (30 Days)
239.1K
743.9K
Earning Date
06-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
0.90
N/A
EPS
1.12
N/A
Revenue
$245,293,000.00
N/A
Revenue This Year
$14.54
$31.62
Revenue Next Year
$18.23
$50.77
P/E Ratio
$92.86
N/A
Revenue Growth
16.86
N/A
52 Week Low
$46.08
$28.54
52 Week High
$125.82
$54.98

Technical Indicators

Market Signals
Indicator
GHM
HROW
Relative Strength Index (RSI) 48.16 51.28
Support Level $88.46 $40.56
Resistance Level $110.01 $41.94
Average True Range (ATR) 5.33 1.99
MACD -1.91 -0.37
Stochastic Oscillator 19.81 12.09

Price Performance

Historical Comparison
GHM
HROW

About GHM Graham Corporation

Graham Corp designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and mixing technologies for the Defense, Energy & Process, and Space industries. In Defense, its equipment is used in nuclear and non-nuclear propulsion, power, fluid transfer, thermal management, and mixing systems. In Energy & Process industries, it supplies equipment for vacuum, heat transfer, mixing, and fluid transfer applications used in oil refining, chemical facilities, fertilizers, ethylene, methanol, energetics, food & beverage, medical, and alternative energy applications such as hydrogen and geothermal processes. In the Space industry, its equipment is used in propulsion, power, thermal management, mixing, and life support systems. It operates in the United States and other countries.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: